Interfor International - COVID-19 Daily Update - Aug 25-midsize

Interfor International – Covid-19 Update – August 25

Interfor’s Covid-19 Updates – August 25, 2020

Latest numbers (as of 9am est):

Total Reported Cases: 23,841,354 (5,916,268 in United States)

Total Deaths: 817,692 (181,286 in United States) 


United States

  • The US Food and Drug Administration issued an emergency use authorization for the use of convalescent plasma to treat Covid-19. The FDA said more than 70,000 patients have been treated with convalescent plasma, made by using the blood of people who have recovered from coronavirus infections.
  • More than 100 students from the University of Southern California are under a 14-day quarantine due to a coronavirus outbreak among students who live in the university’s off-campus housing.
  • Georgia’s Department of Public Health has extended the Covid-19 mega-testing site near Hartsfield-Jackson Atlanta International Airport until September 11. The site currently tests 5,000 people per day and offers results within 48 to 72 hours.
  • New York governor Cuomo said that the Port Authority of New York and New Jersey and NY Health and Hospitals will be setting up new Covid-19 testing sites at John F. Kennedy and LaGuardia airports in New York City to test incoming passengers.
  • Children now represent about 9% of all Covid-19 cases in the US, up from 2% in March according to a recent report from the Children’s Hospital Association and the American Academy of Pediatrics. Most children experience mild or no symptoms, but some are reporting issues that persist for weeks.


  • Brazil’s federal government agency has permitted the humanitarian non-profit Doctors Without Borders to enter indigenous communities and assist with the coronavirus surge there.
  • Colombia announced it is joining a clinical study to develop a coronavirus vaccine. The study will be conducted by pharmaceutical giant Johnson & Johnson across Colombia, the United States, and Belgium with about 60,000 volunteers (aged 18 to 60) taking take part in the study.
  • Belarus will become the first country to receive doses of a potential coronavirus vaccine developed in Russia as part of a new agreement reached by the country’s Presidents. Belarusian citizens will participate in the third stage of vaccine trials on a voluntary basis.
  • Japan recorded 495 new Covid-19 cases, the first time since July 20 that cases have dipped below 500. Despite the slight decrease, the government announced that restrictions capping gatherings to 5,000 people will be extended through the end of September.
  • The director of the Oxford Vaccine Group said that a potential coronavirus vaccine being jointly developed by the University of Oxford and drug maker AstraZeneca could be put before regulators by the end of this year.
  • Germany has issued a travel warning for Paris and the Cote d’Azur region of southeastern France due to high levels of coronavirus infections. Travelers returning from these regions will be required to get a free coronavirus test upon arrival and could be obligated to quarantine for 14 days. 


WARNING:  Be sure to vet ALL information and rumors.